• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2019-08-07 17:04 原文鏈接: ThrombinCleavageofGSTFusionprotein

    INTRODUCTION

    In many cases the cleavage can be performed using the free intact fusion, or in same cases with the fusion protein bound to a matrix. 
    The amount of thrombin, temperature and length of incubation must be calibrated for each system. Samples must be removed at various time points and analyzed by PAGE-SDS to estimate the yield, purity and extent of thrombin digestion. Excess thrombin may result in unwanted proteolysis at secondary sites. 
    Avoid the presence of serine-protease inhibitors (like PMSF or AEBSF) during reaction. 
    Theoretically, cleavage must be complete following ON treatment with <10 cleavege unit per mg protein. For some applications thrombin (MW 37kDa) must be subsequently removed from the sample by chromatography or affinity with pAminoBenzamidine - Agarose. 
      
     

    Reagents required

    Thrombin: from Pharmacia. Dissolve 500 cleavage units in 0.5ml cold PBS. Swirl gently to dissolve. To preserve activity keeps the enzyme in aliquots at -80°C. 
    Thrombin (MW 37kDa) ~4500units/mg. One unit cleaves theoretical 100ug protein in 16hr at 22°C in buffer. 
    Another possibility is to use high purity enzyme from Sigma # T-6884: 3-10 U of thrombin can be used to cleave 1 mg of fusion protein at room temperature overnight.

    1 X PBS buffer: 140mM NaCl; 2.7mM KCL; 10mM Na2HPO4; 1.8mM KH2PO4; pH 7.3  

    Thrombin Cleavage of Free Eluted Fusion protein

    First you have to calibrate amount of thrombin, temperature and length of incubation, taking in mind that one unit cleaves theoretical 100ug protein in 16hr at 22°C in buffer. 
    You can incubate enough eluate to see on PAGE-SDS gels (~3ug) with 0.01, 0.03 & 0.06 Units of thrombin 2hr, 4hr, 6hr & ON at 22°C (or RT). Stop the reaction with PAGE-SDS sample buffer + 1mM PMSF and keep immediately at -20°C until use. Analyze PAGE-SDS gels versus a control of non-cleavaged protein. 
    Longer incubation, more enzyme or higher temperature will increase cleavage; while lower incubation, less enzyme or lower temperature will decrease cleavage.

    As a general protocol you can use:

    1. To the eluate from either batch or column purification, add 10ul of thrombin solution (10 cleavage units) per mg fusion protein. 
    2. Mix gently and incubate at RT for 2-16hrs 
    3. Once digestion is complete you can stop protease cleavage with 1mM PMSF or AEBSF (more stable) and check results by PAGE-SDS gels or immediately separate the cleavage products by chromatography 
    4. When a satisfactory condition is found, scale-up the reaction proportionally. 
      
    Avoid the presence of serine protease inhibitors (like PMSF or AEBSF) during cleavage 

    According to NOVAGEN (pdf) to enhance cleavage of some recombinant proteins, it is possible to carry out thrombin digestion in the presence of protein denaturants, such as 0.01% SDS, 1M urea, and 10% glycerol, which may expose the cleavage site to the enzyme more effectively and/or keep proteins in solution. 

    Thrombin Cleavage of Fusion protein Bound to column matrix

    First you have to calibrate the amount of thrombin, temperature and length of incubation, taking in mind that one unit cleaves theoretical 100ug protein in 16hr at 22°C in buffer or one unit cleaves theoretical 20ul of bed volume saturated resin in 16hr at 22°C in buffer.

    You can incubate 20ul of bed volume saturated resin with 0.1, 0.5, 1 & 2 Units of thrombin (in 20ul total PBS) 2hr, 4hr, 6hr & ON at 22°C (or RT). Stop reaction by spinning for 4min 3000rpm, separate supernatant from beads, and add PAGE-SDS sample buffer + 1mM PMSF  to the supernatant, and keep immediately at -20°C until use. Analyze PAGE-SDS gels versus a control of non-cleavaged protein (eluted non cleaved protein). 
    Longer incubation, more enzyme or higher temperature will increase cleavage; while lower incubation, less enzyme or lower temperature will decrease cleavage.

    As a general protocol you can use:

    1. For 1ml of bed volume saturated resin, mix 50Units of thrombin solution in 1ml PBS. Gently swirl to mix. Shake or rotate at 22°C (or RT) 2-16hrs 
    2. Spin the suspension 4min 3000rpm to pellet the beads. Keep supernatant aside. You can stop protease cleavage with 1mM PMSF or AEBSF (more stable). 
    3. Extract beads twice or more with 1ml PBS or buffer. Keep each supernatant aside. 
    4. As a control you can elute the remaining uncleaved protein (still attached to the resin through the GST) by extraction several times with elution buffer. 
    5. Check results by PAGE-SDS gels or immediately separate the cleavage products by chromatography. 
    6. When a satisfactory condition is found, scale-up the reaction proportionally. 
      
     

    Thrombin Removal with pAmino benzamidine-Agarose

    50 units of Thrombin can be removed by shaking or rotating at 22°C (or RT) 30 min with 100ul with pAminoBenzamidine-Agarose (SIGMA #A 7155).


    相關文章

    因美納推出Illumina?ProteinPrep,驅動更深入的蛋白質組學洞察,助力藥物發現與開發

    IlluminaProteinPrep可檢測9,500種獨特的人類蛋白質靶標,為蛋白質生物學提供全新洞察,推動疾病治療新發現早期試用客戶充分認可了其大規模檢測能力、高度一致性以及簡便的“從樣本到洞察”......

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    ProteinCell:病毒感染時翻譯后修飾乙酰化的動態調控

    天然免疫應答是機體應對病原微生物入侵的第一道防線,在殺傷病原微生物、清除感染細胞和維持體內穩態等方面發揮關鍵作用。蛋白質翻譯后修飾(proteinpost-translationalmodificat......

    Protein&Cell丨劉平生團隊發現脂滴和線粒體相互錨定接觸

    脂滴是一種具有中性脂質核心的膜性細胞器。與其他膜性細胞器的根本區別就是脂滴由單分子磷脂膜包被,而其他膜性細胞器由雙分子磷脂膜與外界隔離。脂滴最早由列文虎克于1674年在牛奶里發現,是人類最早發現的膜性......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    SCIEX攜手ProteinMetrics公司實現生物制藥AI及數據自動化

    分析測試百科網訊隨著生命科學產業的數字化轉型和向精密醫學的推進,集成以增強SCIEX高分辨率精確大眾平臺的快速數據處理能力繼續推動數據需求。生命科學分析技術領域專業企業——SCIEX宣布與蛋白質特性質......

    llumina宣布推出新型基因分型芯片|支持AllofUs研究計劃

    2018年12月6日,來自圣迭戈的消息——Illumina公司(納斯達克股票代碼:ILMN)今天宣布推出新型高密度基因分型芯片Infinium?GlobalDiversityArray。這款芯片設計源......

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频